Get the Stockscreener App
2.50
3.58%
-0.12
Sunshine Biopharma Inc stock is traded at $2.50, with a volume of 36,653.
It is down -3.58% in the last 24 hours and down -19.54% over the past month.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.
See More
Previous Close:
$2.62
Open:
$2.62
24h Volume:
36,653
Relative Volume:
0.06
Market Cap:
$7.10M
Revenue:
$32.96M
Net Income/Loss:
$-4.23M
P/E Ratio:
-0.0161
EPS:
-155.3294
Net Cash Flow:
$-14.00M
1W Performance:
-11.48%
1M Performance:
-19.54%
6M Performance:
-17.22%
1Y Performance:
-99.47%
1-Day Range:
$2.50
$2.64
1-Week Range:
$2.50
$2.85
52-Week Range:
$2.1056
$500.00
Sunshine Biopharma Inc Stock (SBFM) Company Profile
Name
Sunshine Biopharma Inc
Sector
Phone
954-515-0810
Address
333 LAS OLAS WAY, FORT LAUDERDALE
Compare SBFM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SBFM
Sunshine Biopharma Inc
|
2.5109 | 7.10M | 32.96M | -4.23M | -14.00M | -155.33 |
|
ZTS
Zoetis Inc
|
171.50 | 78.56B | 9.15B | 2.43B | 2.31B | 5.32 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.54 | 43.15B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
9.54 | 43.00B | 14.26B | 1.55B | 0 | 0.3383 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.64 | 19.59B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
124.25 | 15.24B | 2.24B | 385.90M | 440.10M | 3.73 |
Sunshine Biopharma Inc Stock (SBFM) Latest News
Sunshine Biopharma (NASDAQ:SBFMW) Trading 30% Higher – Should You Buy? - Defense World
Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54% - ACCESS Newswire
Sunshine Biopharma (NASDAQ:SBFM) Stock Quotes, Forecast and News Summary - Benzinga
Who’s Hired? Haruvi Returns For A Second Term As AAM Chair - News & Insights
Sunshine Biopharma launches Olanzapine and Olanzapine ODT - Indian Pharma Post
Sunshine Biopharma introduces new generic drugs in Canada - MSN
Sunshine Biopharma Appoints New Chief Commercial Officer - MSN
Sunshine Biopharma Launches Generic Mental Health Drug in Rapidly Growing Canadian Market - StockTitan
Sunshine Biopharma Appoints Michel Roy as Chief Commercial Officer - Defense World
Sunshine Biopharma appoints Michel Roy as CCO - MSN
Sunshine Biopharma names new Chief Commercial Officer By Investing.com - Investing.com South Africa
Sunshine Biopharma names new Chief Commercial Officer - Investing.com
Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer - WICZ
Sunshine Biopharma, Inc. (NASDAQ:SBFM) Short Interest Down 14.6% in December - Defense World
Sunshine Biopharma Inc. Elects New Directors and Ratifies Appointment of Independent Registered Public Accounting Firm - Defense World
Sunshine Biopharma re-elects board, ratifies CPA firm By Investing.com - Investing.com Nigeria
Sunshine Biopharma re-elects board, ratifies CPA firm - Investing.com India
Sunshine Biopharma’s PLpro inhibitor shows activity in SARS-CoV-2 - BioWorld Online
Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus - AccessWire
Sunshine Biopharma's Novel COVID-19 Oral Treatment Shows Breakthrough Antiviral Activity in Preclinical Study - StockTitan
Sunshine Biopharma Launches a New Generic Prescription Drug - AccessWire
Sunshine Biopharma Launches Generic Allergy Drug in $1.3B Global Bilastine Market - StockTitan
Mouse model studies provide proof of concept for Sunshine Biopharma’s K1.1 mRNA product for HCC - BioWorld Online
Sunshine Biopharma Announces Breakthrough Research Results on the Company’s K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma - AccessWire
Sunshine Biopharma's K1.1 mRNA Shows Breakthrough Results in Liver Cancer Treatment - StockTitan
SBFM (Sunshine Biopharma) Cash From Discontinued Investing Activities : $0.00 Mil (TTM As of Sep. 2024) - GuruFocus.com
SBFM (Sunshine Biopharma) Operating Income : $-4.91 Mil (TTM As of Sep. 2024) - GuruFocus.com
SBFM (Sunshine Biopharma) Change In Working Capital : $-7.80 Mil (TTM As of Sep. 2024) - GuruFocus.com
SBFM (Sunshine Biopharma) Debt-to-Equity : 0.02 (As of Sep. 2024) - GuruFocus.com
Alkermes (ALKS) Stock Surges Over 5% Amid Strong Financial Perfo - GuruFocus.com
Stock market today: SKK Holdings Limited +81.83%, Palladyne AI Corp. +50.51% among top gainers in early trading - Business Upturn
Sunshine Biopharma launches generic prescription drug - TipRanks
Sunshine Biopharma launches generic liver drug in Canada - Investing.com
Sunshine Biopharma Launches New Generic Drug in $933M Growing Market | SBFM Stock News - StockTitan
Sunshine Biopharma stock hits 52-week low at $2.3 amid sharp decline - Investing.com Canada
Canopy Growth (CGC) Stock Dives Amid Financial Struggles and Ind - GuruFocus.com
CRON Experiences Significant Stock Dip Amid Market Volatility - GuruFocus.com
Sunshine Biopharma Inc. Warrant (SBFMW) Quarterly 10-Q Report - Quartz
SBFM (Sunshine Biopharma) Shares Outstanding (EOP) : 1.17 Mil (As of Jun. 2024) - GuruFocus.com
Canopy Growth Corporation (CGC) Stock Declines Amid Financial Re - GuruFocus.com
Bloomin’ Brands (NASDAQ:BLMN) Rating Increased to Hold at StockNews.com - Defense World
StockNews.com Begins Coverage on Accelerate Diagnostics (NASDAQ:AXDX) - Defense World
First Citizens Bancshares (OTC:FIZN) Stock Price Down 4.3% – Should You Sell? - Defense World
DBV Technologies (NASDAQ:DBVT) Research Coverage Started at StockNews.com - Defense World
JATT Acquisition (NYSE:JATT) Trading Down 2.7% – Should You Sell? - Defense World
Sunshine Biopharma Strengthens Leadership with New Executive Agreements - TipRanks
Elanco Animal Health (ELAN) Stock Drops 5% Amidst Industry Decli - GuruFocus.com
Sunshine Biopharma, Inc. (NASDAQ:SBFM) Short Interest Up 66.8% in September - MarketBeat
Sunshine Biopharma Inc Stock (SBFM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sunshine Biopharma Inc Stock (SBFM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Slilaty Steve N. | Chief Executive Officer |
Feb 08 '24 |
Buy |
0.10 |
20,000 |
2,000 |
30,000 |
1.05%
2.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):